Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-139358

Options or other derivatives

  • Director acquired 184,562 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sigal Charles Elliott Director 2016-08-11 Grant or award · Option to purchase Ordinary Shares +184,562 184,562 D: show line 1 in the form
Loading xslF345X03/a4.xml…